Highlights
- Market Cap
- $8.58B
- Enterprise Value
- $8.46B
- EPS (TTM)
- $3.18
- PE Ratio
- 25.76
- PEG Ratio
- 0.67
- Total Revenue (TTM)
- $425.10M
- Gross Profit (TTM)
- $372.88M
- EBITDA (TTM)
- $322.51M
- Year Range
- $74.52 - $218.25
- Target Price
- $155.00
- ROA (TTM)
- 62.38%
- ROE (TTM)
- 85.63%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Pro Medicus Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Pro Medicus Ltd (PMCUF) has returned -43.50% so far this year and -36.71% over the past 12 months.
Pro Medicus Ltd
- 1D
- 3.16%
- 1M
- 1.91%
- YTD
- -43.50%
- 6M
- -59.37%
- 1Y
- -36.71%
- 3Y*
- 23.63%
- 5Y*
- 20.70%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Sep 25, 2017, PMCUF's average daily return is +0.21%, while the average monthly return is +3.98%. At this rate, your investment would double in approximately 1.5 years.
Historically, 62% of months were positive and 38% were negative. The best month was May 2025 with a return of +48.4%, while the worst month was Feb 2026 at -38.6%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 5 months.
On a daily basis, PMCUF closed higher 32% of trading days. The best single day was May 7, 2025 with a return of +30.0%, while the worst single day was Feb 12, 2026 at -23.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.72% | -38.59% | 1.91% | -43.50% | |||||||||
| 2025 | 7.64% | -5.85% | -17.28% | -8.75% | 48.37% | 5.11% | 9.64% | -1.52% | 1.38% | -19.07% | -2.14% | -9.19% | -6.07% |
| 2024 | 1.93% | 0.59% | 1.17% | 8.24% | 10.67% | 15.80% | -4.00% | 12.75% | 19.71% | 8.33% | 21.54% | -1.73% | 141.27% |
| 2023 | 29.78% | -11.60% | 6.90% | -4.35% | -8.57% | 11.64% | 7.39% | 2.37% | 9.26% | -0.27% | 11.11% | 13.60% | 81.01% |
| 2022 | -31.61% | -1.19% | 19.74% | -4.96% | -13.31% | -3.42% | 20.17% | 5.74% | -6.69% | 0.54% | 15.69% | -10.00% | -20.09% |
| 2021 | 23.93% | 6.97% | -5.50% | 8.73% | -3.79% | 26.51% | 0.07% | 3.89% | -11.30% | -1.89% | 7.25% | 7.19% | 72.43% |
Benchmark Metrics
Pro Medicus Ltd has an annualized alpha of 61.42%, beta of 0.36, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since September 26, 2017.
- This stock captured 187.48% of S&P 500 Index gains but only 59.82% of its losses — a favorable profile for investors.
- Beta of 0.36 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 61.42%
- Beta
- 0.36
- R²
- 0.02
- Upside Capture
- 187.48%
- Downside Capture
- 59.82%
Return for Risk
Risk / Return Rank
PMCUF ranks 20 for risk / return — in the bottom 20% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Pro Medicus Ltd (PMCUF) and compare them to a chosen benchmark (S&P 500 Index).
| PMCUF | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.49 | 0.90 | -1.38 |
Sortino ratioReturn per unit of downside risk | -0.33 | 1.39 | -1.72 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.21 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | -0.57 | 1.40 | -1.96 |
Martin ratioReturn relative to average drawdown | -1.26 | 6.61 | -7.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore PMCUF risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Pro Medicus Ltd provided a 0.40% dividend yield over the last twelve months, with an annual payout of $0.33 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Dividend | $0.33 | $0.23 | $0.53 | $0.28 | $0.22 | $0.16 |
Dividend yield | 0.40% | 0.15% | 0.34% | 0.43% | 0.61% | 0.36% |
Monthly Dividends
The table displays the monthly dividend distributions for Pro Medicus Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.33 | $0.00 | $0.33 | |||||||||
| 2025 | $0.00 | $0.23 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.23 |
| 2024 | $0.00 | $0.17 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.53 |
| 2023 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.00 | $0.28 |
| 2022 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.00 | $0.22 |
| 2021 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.16 |
Dividend Yield & Payout
Dividend Yield
Pro Medicus Ltd has a dividend yield of 0.40%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Pro Medicus Ltd has a payout ratio of 29.81%, which is quite average when compared to the overall market. This suggests that Pro Medicus Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Pro Medicus Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Pro Medicus Ltd was 66.06%, occurring on Mar 19, 2020. Recovery took 186 trading sessions.
The current Pro Medicus Ltd drawdown is 62.30%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -66.06% | Aug 30, 2019 | 136 | Mar 19, 2020 | 186 | Dec 18, 2020 | 322 |
| -64.88% | Jul 23, 2025 | 149 | Feb 24, 2026 | — | — | — |
| -45.65% | Feb 26, 2025 | 29 | Apr 7, 2025 | 60 | Jul 3, 2025 | 89 |
| -45.3% | Aug 25, 2021 | 205 | Jun 16, 2022 | 158 | Feb 2, 2023 | 363 |
| -31.49% | Oct 2, 2018 | 14 | Oct 29, 2018 | 47 | Jan 15, 2019 | 61 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Pro Medicus Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Pro Medicus Ltd is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PMCUF, comparing it with other companies in the Health Information Services industry. Currently, PMCUF has a P/E ratio of 25.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PMCUF compared to other companies in the Health Information Services industry. PMCUF currently has a PEG ratio of 0.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PMCUF relative to other companies in the Health Information Services industry. Currently, PMCUF has a P/S ratio of 20.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PMCUF in comparison with other companies in the Health Information Services industry. Currently, PMCUF has a P/B value of 22.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |